Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A prospective study of patients with brain MRI showing incidental t2 hyperintensities addressed as multiple sclerosis: a lot of work to do before treating.
Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis.
Comments on "first-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis"
B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions.
Heterodimerization of p45-p75 Modulates p75 Signaling: Structural Basis and Mechanism of Action.
Apoptosis of Oligodendrocytes during Early Development Delays Myelination and Impairs Subsequent Responses to Demyelination.
Nonconventional MRI and microstructural cerebral changes in multiple sclerosis.
Intractable nausea and vomiting as presenting manifestation of neuromyelitis optica.
Glatiramer acetate-induced lobular panniculitis and skin necrosis.
Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects.
Identifying environmental antigens that activate myelin-specific T cells.
Carer quality of life and experiences of health services: a cross-sectional survey across three neurological conditions.
Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents α-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy.
Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis.
Protective effects of matrine on experimental autoimmune encephalomyelitis via regulation of ProNGF and NGF signaling.
Diffusion-weighted imaging as an aid in the diagnosis of the etiology of medial longitudinal fasciculus syndrome.
Optic neuritis following aseptic meningitis associated with modified measles: a case report.
Deficits in tongue motor control are linked to microstructural brain damage in multiple sclerosis: a pilot study.
Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset.
[Use of vitamins for correction of the functional state of cytochrome P450 systems at experimental allergic encephalomyelitis].
Alteration of delta-6-desaturase (FADS2), secretory phospholipase-A2 (sPLA2) enzymes by Hot-nature diet with co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.
Regulation of IL-17 in autoimmune diseases by transcriptional factors and microRNAs.
A critical role for interleukin-1β in the progression of autoimmune diseases.
High-throughput sequencing of immune repertoires in multiple sclerosis.
Pages
« first
‹ previous
…
602
603
604
605
606
607
608
609
610
…
next ›
last »